Skip to content

Comparing effect of sevoflurane ,a inhalational anaesthetic, and propofol , a intravenous anaesthetic, on postoperative confusion after elective brain tumour resection surgery

Comparison of sevoflurane and propofol on postoperative delirium in patients undergoing elective brain tumour resection – randomised control double blinded study. - nil

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/08/056663
Enrollment
392
Registered
2023-08-21
Start date
Unknown
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D496- Neoplasm of unspecified behavior of brain

Interventions

Intervention1: nil: nil Control Intervention1: sevoflurane: sevoflurane - inhalational anesthetic agent which is given after induction of anaesthesia through endotracheal tube at a concentration to m

Sponsors

Sree Chitra Tirunal Institute for Medical Scinences and Technology Thiruvananthapuram
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age > 18yrs ASA grade 1 & 2 GCS 15 prior to surgery Elective intracranial tumour resection

Exclusion criteria

Exclusion criteria: Chronic alcoholism Prior history of psychiatric disease Pregnancy Hepatic or renal derangements Epilepsy surgeries Patients on mechanical ventilation for > 72 hrs post surgery Patients with bilateral hearing loss or blindness. Redo surgery within 48 hrs.

Design outcomes

Primary

MeasureTime frame
To find incidence of post operative delirium in sevoflurane & propofol in patients undergoing elective brain tumour resection.Timepoint: post op day 7

Secondary

MeasureTime frame
To find risk factors for post operative delirium in sevoflurane & propofol in patients undergoing elective brain tumour resection.Timepoint: post op day 7

Countries

India

Contacts

Public ContactAnjane Sree

sree chitra tirunal institute for medical sciences and technology

anjanesree@gmail.com8148103365

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026